-
Oxford Nanopore Launches cDNA Kits
Feb 5, 2019, 11:45 AM by Michael CroftBio-IT World News Brief Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology. The new kits provide high throughput while generating complete sequences of full-length cDNA strands, with a low input option of just 1 ng PolyA+ RNA.Full story -
IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Feb 5, 2019, 10:17 AM by Michael CroftDANBURY, CT - Feb 4, 2019 - (BUSINESS WIRE) - IQVIA (NYSE:IQV) today announced the launch of IQVIA Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companiesFull story -
CRISPR's Gene Editing Toolbox Is Expanding
Feb 5, 2019, 09:52 AM by Michael CroftLos Angeles Times | The scientists who developed the revolutionary gene-editing system known as CRISPR are improving it with new tools that make it work better.Full story -
Genedata Announces Bruker as a New Ready-to-Run Partner
Feb 5, 2019, 09:17 AM by Michael CroftWASHINGTON, DC, UNITED STATES - Feb 5, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced Bruker, a preeminent provider of high-performance scientific instruments and high-value analytical and diagnostic solutions, as a new Genedata Ready-to-Run partnerFull story -
GA4GH Adds Seven Genomic Data Initiatives As New Driver Projects
Feb 4, 2019, 16:35 PM by Michael CroftFull storyBio-IT World News Brief | The Global Alliance for Genomics and Health (GA4GH) has named seven of the world’s leading genomic data initiatives as new Driver Projects for 2019.
-
Rho Sponsoring Smile Train Triathlon for fourth year in a Row
Feb 4, 2019, 14:18 PM by Michael CroftCHAPEL HILL - Feb 5, 2019 - For Immediate Release Smile Train Triathlon Taking Place June 23 in Wake ForestRho sponsoring event for fourth year in a row,CEO Russ Helms is a nine-time Triathlete, Born with Cleft Lip and Palate Chapel Hill, NC ̶ February 4, 2019 ̶ Rho, a Chapel Hill-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, is the 2019 Title Sponsor of the 12th annual Smile Train Triathlon taking place Sunday, June 23 in Wake ForestFull story -
New Web-based Genedata Screener Showcases at SLAS 2019
Feb 4, 2019, 09:57 AM by Michael CroftWASHINGTON, DC, UNITED STATES OF AMERICA - Feb 4, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced the release of its new web-based Genedata Screener® 16 at the SLAS 2019 – 8th Annual Conference and ExhibitFull story -
Collaboration And Machine Learning Key For 23andMe’s Drug Discovery Efforts
Jan 31, 2019, 09:45 AM by Michael CroftFull storyBio-IT World | 23andMe is at the forefront of a collaborative effort to forge partnerships with pharma companies and research institutes to improve drug discovery, as well as use resources to capitalize on the growth of personalized medicine.
-
TrialScope and Vivli Partner to Address Rapidly Growing Transparency Needs of Clinical Trial Sponsors and Researchers
Jan 30, 2019, 13:05 PM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jan 29, 2019 - TrialScope, the global leader in clinical trial transparency, compliance and patient engagement solutions, today announced a strategic partnership with Vivli, a nonprofit organization focused on sharing of clinical trial data through its innovative platformFull story -
Copyright Clearance Center, PAREXEL, Eaton, And More: News From January 2019
Jan 30, 2019, 11:40 AM by Michael CroftFull storyBio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Copyright Clearance Center, PAREXEL, Eaton, and more.
-
WCG Acquires First Clinical Research, LLC
Jan 30, 2019, 08:30 AM by Michael CroftPRINCETON, NJ - Jan 30, 2019 - The WIRB-Copernicus Group®s (WCG) Market Intelligence & Insights Division has acquired First Clinical Research LLC, organizer of the MAGI (Model Agreements & Guidelines International) Clinical Research Conference, which unifies the clinical research ecosystem by facilitating communication and the sharing of best practices among membersFull story -
Certara Launches Version 18 of its Physiologically-based Pharmacokinetic (PBPK) Simcyp Simulator
Jan 29, 2019, 08:26 AM by Michael CroftPRINCETON, NJ - Jan 29, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 18 of its Simcyp® Population-based SimulatorFull story -
Optibrium strengthens senior management team with Financial Director appointment
Jan 28, 2019, 11:28 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Jan 28, 2019 - Optibrium, a developer of software for drug discovery, today announced the appointment of Clare Devlin as Financial DirectorFull story -
Creative BioMart Has Newly Launched Its Stable Cell Line Services
Jan 25, 2019, 22:52 PM by Michael CroftSHIRLEY, NY, 美国 - Jan 26, 2019 - Creative BioMart, a leading provider of high-quality, comprehensive protein products and custom protein manufacturing services for over a decade, has newly launched its stable cell line services for researchers and scientists in need of protein production and assay developmentFull story -
After “CRISPR Babies,” Medical Leaders To Tighten Genome Editing Rules
Jan 24, 2019, 15:00 PM by Michael CroftFull storySTAT | Less than two years after the U.S. National Academy of Medicine produced an exhaustive report on human genome editing, it is planning an international commission on the most controversial use of that technology — creating “CRISPR babies.”
-
Quake Lab Utilizes RNA Sequencing Tool For Food Allergy Diagnostics
Jan 24, 2019, 14:30 PM by Michael CroftFull storyBio-IT World | Researchers in the Stanford lab of Stephen Quake are using single cell RNA sequencing in an effort to provide insight into food allergies and the antibodies that cause them.
-
1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution
Jan 24, 2019, 12:01 PM by Michael CroftST. LOUIS, MO, UNITED STATES - Jan 24, 2019 - 1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop System for use within Partek® Flow® bioinformatics softwareFull story -
Wasdell Group granted HPRA licence at new EU headquarters
Jan 24, 2019, 07:09 AM by Michael Croft- Jan 24, 2019 - The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical and clinical trials industries, has been granted its Health Products Regulatory Authority (HPRA) licence for its new EU headquarters in Dundalk, IrelandFull story -
LG Technology Ventures Makes Strategic Investment in Lygos
Jan 23, 2019, 11:32 AM by Michael CroftBERKELEY, CA, UNITED STATES - Jan 23, 2019 -Full story
Lygos, Inc., a biotechnology-based producer of specialty chemicals that deliver high-value performance without environmental toxicity, today announced that LG Technology Ventures, an investment arm of the South Korean conglomerate LG Group, has made a $5 million investment in its oversubscribed Series B financing round -
IDDI starts Collaborative Research on Ground-Breaking Statistical Method for individualization of Therapy
Jan 23, 2019, 09:09 AM by Michael Croft, BELGIUM - Jan 23, 2019 - The treatment of patients in clinical practice relies on the results of randomized clinical trials. The statistical methods currently used to test the treatment effects in such trials take into account a single criterion called "primary endpoint"Full story